Therapy-Associated Risk for SAE After Radioembolization
| 95% confidence interval | |||||
| Variable | n | P | Odds ratio | Lower bound | Upper bound |
| TAX | 59 | 0.805 | 1.13 | 0.44 | 2.87 |
| ANT | 57 | 0.449 | 1.45 | 0.55 | 3.80 |
| 5-FU/MTX | 22 | 0.805 | 1.13 | 0.44 | 2.87 |
| PBA | 20 | 0.222 | 1.89 | 0.68 | 5.28 |
| CLA | 59 | 0.194 | 1.94 | 0.71 | 5.31 |
| mAb | 35 | 0.043* | 2.33 | 0.95 | 5.73 |
| Other CTx | 43 | 0.448 | 0.71 | 0.30 | 1.71 |
| HTx | 63 | 0.154 | 2.20 | 0.73 | 6.59 |
↵* Significant.
TAX = taxanes; ANT = anthracyclines; 5-FU = fluorouracil; MTX = methotrexate; PBA = platinum-based agents; CLA = DNA cross-link agents; mAb = monoclonal antibodies; CTx = chemotherapy; HTx = hormone therapy.